WallStreetZen

Stock ScreenerStock IdeasBiotech Breakthroughs
Best Biotech Stocks To Buy Now
Top biotech stocks that analysts expect to be profitable within the next 3 years

Industry: Biotechnology
Forecast Earnings Growth: Positive
Ticker
Company
Forecast Score
Market Cap
Price
Price Target
Upside/Downside
Consensus
Analysts
Fore. Revenue Growth
Fore. Earnings Growth
Forecast ROE
Forecast ROA
CLGNCollPlant Biotechnologies Ltd
100
$176.38M$17.79$26.0046.15%Buy152.48%70.43%58.63%52.43%
VCELVericel Corp
89
$2.45B$52.94$42.00-20.66%Strong Buy626.77%103.97%88.94%58.97%
EXELExelixis Inc
89
$5.28B$16.85$33.0095.85%Buy722.71%74.25%26.07%22.75%
HALOHalozyme Therapeutics Inc
89
$5.88B$41.33$52.0025.82%Buy331.18%38.49%730.25%51.07%
CDMOAvid Bioservices Inc
89
$1.57B$25.65$28.009.16%Strong Buy329.01%137.75%66.81%19.56%
BNTXBioNTech SE
78
$79.30B$328.35$173.80-47.07%Hold7112.93%418.96%-53.12%-31.43%
MRNAModerna Inc
78
$141.98B$353.60$187.36-47.01%Buy1353.49%77.07%-18.47%-5.58%
BDSIBiodelivery Sciences International Inc
78
$370.56M$3.76$5.5046.28%Buy115.97%45.01%88.12%39.62%
INCYIncyte Corp
67
$17.01B$77.35$89.6715.92%Buy614.33%31.37%59.90%44.63%
ABCMAbcam plc
67
$4.26B$18.91$22.0016.34%Hold319.46%85.61%15.87%9.83%
UTHRUNITED THERAPEUTICS Corp
56
$8.15B$181.93$227.2024.88%Strong Buy510.85%23.77%26.21%19.45%
RPRXRoyalty Pharma plc
56
$23.19B$38.20$50.5032.20%Strong Buy24.03%32.62%23.70%14.65%
VNDAVanda Pharmaceuticals Inc
56
$907.46M$16.31$18.0010.36%Buy210.99%32.83%25.78%21.86%
JAZZJazz Pharmaceuticals plc
44
$9.65B$169.52$201.5818.91%Buy1217.25%19.44%17.02%9.57%
CORTCorcept Therapeutics Inc
44
$2.41B$20.77$22.337.53%Buy314.36%16.13%38.59%35.48%
LGNDLigand Pharmaceuticals Inc
44
$1.89B$113.51$221.2594.92%Strong Buy411.89%33.14%10.27%5.91%
NBIXNeurocrine Biosciences Inc
44
$8.81B$93.21$122.3831.29%Buy919.43%10.39%59.08%38.57%
REGNRegeneron Pharmaceuticals Inc
33
$61.22B$574.61$622.918.41%Buy118.26%4.30%41.58%28.02%
VRTXVertex Pharmaceuticals Inc
33
$52.18B$201.58$262.1930.07%Buy178.97%2.07%37.99%28.16%
NVONovo Nordisk A S
33
$217.61B$92.60N/AN/AStrong Buy17.32%7.64%101.62%42.04%
OVIDOvid Therapeutics Inc
22
$252.92M$3.73$6.0060.86%Buy4-5.71%40.23%-22.92%-21.35%
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.